Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health In Tech (HIT) Cash & Equivalents (2023 - 2025)

Health In Tech has reported Cash & Equivalents over the past 3 years, most recently at $7.7 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $7.7 million for Q4 2025, down 2.29% from a year ago — trailing twelve months through Dec 2025 was $7.7 million (down 2.29% YoY), and the annual figure for FY2025 was $7.7 million, down 2.29%.
  • Cash & Equivalents for Q4 2025 was $7.7 million at Health In Tech, down from $8.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for HIT hit a ceiling of $8.1 million in Q2 2025 and a floor of $2.4 million in Q4 2023.
  • Median Cash & Equivalents over the past 3 years was $7.8 million (2024), compared with a mean of $6.9 million.
  • Biggest five-year swings in Cash & Equivalents: soared 224.84% in 2024 and later decreased 2.29% in 2025.
  • Health In Tech's Cash & Equivalents stood at $2.4 million in 2023, then soared by 224.84% to $7.8 million in 2024, then decreased by 2.29% to $7.7 million in 2025.
  • The last three reported values for Cash & Equivalents were $7.7 million (Q4 2025), $8.0 million (Q3 2025), and $8.1 million (Q2 2025) per Business Quant data.